Question 1

How does Lumigan® work for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) clinical trial (NCT01632423). Contact the study team or your healthcare provider for specific answers.

Question 2

What should I expect while using this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) clinical trial (NCT01632423). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) clinical trial (NCT01632423). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) clinical trial (NCT01632423). Contact the study team or your healthcare provider for specific answers.

Question 5

What monitoring will I need while on this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) clinical trial (NCT01632423). Contact the study team or your healthcare provider for specific answers.

What this study is about